Landscape Capital Management L.L.C. acquired a new stake in shares of Lemonade, Inc. (NYSE:LMND - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 78,783 shares of the company's stock, valued at approximately $5,608,000. Landscape Capital Management L.L.C. owned about 0.11% of Lemonade as of its most recent filing with the SEC.
Several other institutional investors also recently bought and sold shares of LMND. Caitong International Asset Management Co. Ltd grew its position in Lemonade by 8,080.0% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 409 shares of the company's stock valued at $29,000 after purchasing an additional 404 shares during the last quarter. Strategic Advocates LLC purchased a new stake in Lemonade during the 3rd quarter valued at about $33,000. Northwestern Mutual Wealth Management Co. purchased a new stake in Lemonade during the 4th quarter valued at about $33,000. Torren Management LLC purchased a new stake in Lemonade during the 4th quarter valued at about $35,000. Finally, NewEdge Advisors LLC purchased a new stake in Lemonade during the 1st quarter valued at about $35,000. 80.30% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Lemonade
In other news, insider Maya Prosor sold 1,220 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $53.17, for a total value of $64,867.40. Following the transaction, the insider owned 187,573 shares in the company, valued at $9,973,256.41. This represents a 0.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider John Sheldon Peters sold 3,608 shares of the stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $52.94, for a total transaction of $191,007.52. Following the completion of the transaction, the insider owned 81,386 shares in the company, valued at $4,308,574.84. This trade represents a 4.25% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 6,563 shares of company stock worth $348,125 in the last quarter. Company insiders own 14.70% of the company's stock.
Lemonade Stock Up 0.4%
Shares of NYSE:LMND opened at $57.42 on Friday. The firm's 50 day moving average price is $58.38 and its 200-day moving average price is $66.96. Lemonade, Inc. has a twelve month low of $35.70 and a twelve month high of $99.90. The stock has a market capitalization of $4.41 billion, a PE ratio of -30.71 and a beta of 1.83.
Lemonade (NYSE:LMND - Get Free Report) last issued its quarterly earnings data on Tuesday, April 28th. The company reported ($0.47) earnings per share for the quarter, topping the consensus estimate of ($0.58) by $0.11. Lemonade had a negative net margin of 16.44% and a negative return on equity of 26.52%. The firm had revenue of $258.00 million for the quarter, compared to analysts' expectations of $251.51 million. During the same quarter in the prior year, the business earned ($0.86) EPS. The business's quarterly revenue was up 70.6% on a year-over-year basis. Analysts expect that Lemonade, Inc. will post -1.68 earnings per share for the current fiscal year.
Analysts Set New Price Targets
LMND has been the topic of several recent analyst reports. TD Cowen reissued a "hold" rating on shares of Lemonade in a research report on Monday, June 8th. Truist Financial cut their price objective on shares of Lemonade from $98.00 to $70.00 and set a "buy" rating on the stock in a research report on Wednesday, April 29th. Wolfe Research set a $44.00 price objective on shares of Lemonade in a research report on Tuesday, February 24th. Citizens Jmp cut their price objective on shares of Lemonade from $85.00 to $80.00 and set a "market outperform" rating on the stock in a research report on Thursday, April 30th. Finally, Keefe, Bruyette & Woods raised their price target on shares of Lemonade from $40.00 to $44.00 and gave the company an "underperform" rating in a report on Tuesday, February 24th. Five analysts have rated the stock with a Buy rating, two have given a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $64.89.
Check Out Our Latest Stock Report on LMND
Lemonade Profile
(
Free Report)
Lemonade, Inc NYSE: LMND is a New York–based technology-driven insurance carrier that leverages artificial intelligence and behavioral economics to streamline the purchase and management of policies. Founded in 2015, the company offers renters, homeowners, pet, term life and car insurance products tailored for digitally savvy consumers. By automating underwriting and claims processing through chatbots and machine learning, Lemonade aims to deliver a more transparent and user-friendly experience than traditional insurers.
The company's product suite includes standalone policies for renters and homeowners, customizable pet insurance plans, and term life coverage with simple online applications.
See Also
Want to see what other hedge funds are holding LMND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lemonade, Inc. (NYSE:LMND - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lemonade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lemonade wasn't on the list.
While Lemonade currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.